Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Fidelio Capital in connection with acquisition of BioMedtrix
Mandate

Vinge advises Fidelio Capital in connection with acquisition of BioMedtrix

March 18, 2020 M&A

Vinge has advised Fidelio Capital on the acquisition of BioMedtrix, LLC. BioMedtrix is a leading company within the market for veterinary orthopedic implants and instruments.

The company is based in New Jersey, USA, and sells its products to over 35 markets world-wide.

Vinge’s team consisted of, among others, Jonas Bergström and Manne Bergström.

Related

Vinge represents Triton in connection with the sale of Aleris

 Vinge has represented Triton in connection with the sale of Aleris to Mehiläinen Group.
May 18, 2026

Vinge advises L5 Navigation in connection with the acquisition of Lundaman Instrument

 L5 Navigation Systems AB has acquired the shares in Lundaman Instrument AB. Lundaman develops and supplies weighing systems for wheel loaders and forklift trucks, focusing on the construction, recycling, industrial and materials handling sectors.
May 13, 2026

Vinge advises Aonic in connection with the issuance of subsequent senior secured bonds of EUR 25 million

 Vinge has advised Aonic AB (publ) in connection with the issuance of subsequent senior secured bonds of EUR 25 million, and parallel written procedure to increase the bond framework to EUR 150 million.
May 12, 2026